(Q28082017)

Pietro E. Cippà

series ordinal

2

1 reference

Nicolas J. Mueller

series ordinal

3

1 reference

language of work or name

1 reference

December 2015

1 reference

published in

Transplant International

1 reference

volume

28

1 reference

issue

12

1 reference

page(s)

1351-6

1 reference

Human cytomegalovirus and kidney transplantation: a clinician's update

cites work

1 reference

Viral impact on long-term kidney graft function

21 January 2018

1 reference

Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation

21 January 2018

1 reference

State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician

21 January 2018

1 reference

Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection

21 January 2018

1 reference

Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients

21 January 2018

1 reference

Comparative analysis of assays for detection of cell-mediated immunity toward cytomegalovirus and M. tuberculosis in samples from deceased organ donors.

21 January 2018

1 reference

Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation

21 January 2018

1 reference

Tacrolimus/mycophenolate mofetil improved natural killer lymphocyte reconstitution one year after kidney transplant by reference to cyclosporine/azathioprine.

21 January 2018

1 reference

Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results

21 January 2018

1 reference

Increase of infectious complications in ABO-incompatible kidney transplant recipients--a single centre experience.

21 January 2018

1 reference

Cytomegalovirus infection after acute rejection therapy in seropositive kidney transplant recipients

21 January 2018

1 reference

A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation

21 January 2018

1 reference

Prophylaxis of primary cytomegalovirus disease in renal transplant recipients. A trial of ganciclovir vs immunoglobulin

21 January 2018

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

Oral valgancyclovir versus intravenous gancyclovir for cytomegalovirus prophylaxis in kidney transplant recipients.

21 January 2018

1 reference

A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients.

21 January 2018

1 reference

Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: results of a randomized clinical trial

21 January 2018

1 reference

A direct and indirect comparison meta-analysis on the efficacy of cytomegalovirus preventive strategies in solid organ transplant

21 January 2018

1 reference

Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients

21 January 2018

1 reference

Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial

21 January 2018

1 reference

Poor outcomes associated with neutropenia after kidney transplantation: analysis of United States Renal Data System.

21 January 2018

1 reference

A stringent preemptive protocol reduces cytomegalovirus disease in the first 6 months after kidney transplantation.

21 January 2018

1 reference

Immune activation following cytomegalovirus infection: more important than direct viral effects in cardiovascular disease?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRI.12629

0 references

PubMed publication ID

26138458

1 reference